Prevalence and risk factors of eligibility for anti-osteoporosis medication in a cohort of men ≥50 years and postmenopausal women who had already experienced bariatric surgery
The 2022 recommendations of the European Calcified Tissue Society (ECTS) suggest initiating anti-osteoporotic medication (AOM) in case of a T-score ≤ −2 and/or in case of a fragility fracture within less than 2 years. Therefore, this study aimed to evaluate the eligibility for AOM in a cohort of pat...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica
2025-10-01
|
| סדרה: | Endocrine Connections |
| נושאים: | |
| גישה מקוונת: | https://ec.bioscientifica.com/view/journals/ec/14/10/EC-25-0368.xml |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|